• Faropenem Sodium: Penem Antibiotic Workflows for AMR Researc

  2026-05-29

  Faropenem sodium stands out as a potent penem antibiotic for both Gram-positive and Gram-negative bacterial inhibition, with unique stability against β-lactamases and exceptional anaerobic activity. This article guides researchers through practical workflows, nuanced troubleshooting, and cutting-edge resistance models, leveraging APExBIO’s rigorously validated Faropenem sodium (SKU C8712) as a core tool for antimicrobial research.

• Redefining mRNA Delivery: Mechanistic and Translational Insi

  2026-05-28

  Explore how EZ Cap™ Cy5 EGFP mRNA (5-moUTP) empowers translational researchers to unravel the mechanistic intricacies of mRNA delivery, optimize LNP formulation strategies, and drive progress in gene regulation studies with dual-fluorescence precision. This article bridges recent biophysical advances with actionable guidance for experimental design, moving beyond standard product narratives.

• GLT-1 Upregulation Mitigates TBI via CB1-CREB Pathway Inhibi

  2026-05-28

  This study uncovers how upregulating GLT-1 in astrocytes protects against neuronal apoptosis and cognitive dysfunction after traumatic brain injury (TBI) by inhibiting the CB1-CREB signaling pathway. The findings suggest new mechanistic targets for modulating excitotoxicity and cognitive outcomes in neurotrauma models.

• Arrb2-Driven M2 Macrophage Polarization Mitigates Liver IRI

  2026-05-27

  This study reveals that hepatocyte-specific Arrb2 expression promotes M2 macrophage polarization and alleviates hepatic ischemia-reperfusion injury (IRI) by upregulating the metabolite 6-ketoLCA. These findings provide a mechanistic framework for targeting hepatocyte-macrophage interaction to improve outcomes in liver transplantation.

• In Situ TIL Therapy via Local mRNA Delivery: New Immunothera

  2026-05-27

  This study introduces a novel approach to tumor-infiltrating lymphocyte (TIL) therapy, using local mRNA delivery to engineer both tumor cells and macrophages for direct in situ T cell activation and expansion. The findings demonstrate significant antitumor effects and offer a practical alternative to complex ex vivo TIL preparation.

• Cy5-UTP: Illuminating RNA Trafficking & Endosomal Escape in

  2026-05-26

  Explore how Cy5-UTP (Cyanine 5-UTP) advances live-cell RNA tracking and endosomal escape analysis. This article combines molecular insight with practical protocol guidance for next-generation RNA labeling workflows.

• Cy5-UTP (Cyanine 5-UTP): Illuminating RNA Regulatory Network

  2026-05-26

  Explore how Cy5-UTP (Cyanine 5-uridine triphosphate) enables advanced RNA probe synthesis for dissecting RNA–RNA and RNA–protein interactions. This in-depth article uniquely connects fluorescent RNA labeling with the latest insights into mRNA processing and alternative splicing, offering practical guidance for molecular biology research.

• WY-14643 (Pirinixic Acid): Advanced Protocols in Metabolic R

  2026-05-25

  WY-14643 (Pirinixic Acid) stands out for its robust, selective PPARα activation, enabling translational breakthroughs in metabolic and inflammation research. This guide delivers actionable experimental workflows, troubleshooting insights, and highlights a recent study on liver regeneration, showcasing how to leverage APExBIO’s WY-14643 for reproducible, high-impact data.

• BMN 673 (Talazoparib): Precision PARP Inhibition for DNA Rep

  2026-05-25

  Explore the advanced scientific basis and experimental implications of BMN 673 (Talazoparib) as a selective PARP1/2 inhibitor. This article offers unique mechanistic insights and practical guidance for leveraging BMN 673 in DNA repair deficiency and homologous recombination research.

• Cholecystokinin Octapeptide Ammonium: Applied Research Workf

  2026-05-24

  Cholecystokinin octapeptide ammonium (CCK-8 ammonium) empowers neurobiology and immunology labs with robust mechanistic control over apoptosis, anxiety modeling, and peptide signaling. This guide translates recent bench research into actionable protocols, troubleshooting strategies, and advanced applications—ensuring reproducibility and interpretability for both established and emerging assays.

• EZ Cap Cy5 Firefly Luciferase mRNA: Dual-Mode mRNA Tracking

  2026-05-23

  EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) empowers researchers to visualize and quantify mRNA delivery and expression in real time, combining the sensitivity of bioluminescence with Cy5 fluorescence in a single reagent. Its Cap1 capping and 5-moUTP modification deliver robust translation and minimal innate immune activation, streamlining transfection optimization and advanced intracellular trafficking studies.

• Reelin-SFK Signaling Is Essential for Ketamine’s Antidepress

  2026-05-22

  This study demonstrates that intact synaptic Reelin signaling through Apoer2 and Src family kinases (SFKs) is required for the rapid antidepressant and synaptic actions of ketamine in the hippocampus. The findings reveal why disruptions in Reelin-SFK pathways may underlie nonresponsiveness to ketamine, providing new mechanistic insight for depression research.

• CD44-Driven Metabolic Rewiring in IDH-Mutant AML: Therapeuti

  2026-05-22

  This study uncovers a critical role for CD44 in sustaining NADPH-dependent production of the oncometabolite 2-hydroxyglutarate in IDH-mutant acute myeloid leukemia. By mapping the metabolic adaptations driven by CD44, the research identifies a targetable vulnerability in these malignancies—one that may enhance the efficacy of mutant IDH1 inhibition strategies.

• Targeted mRNA Delivery to Islet β Cells Using Lipid Nanopart

  2026-05-21

  Enriquez et al. demonstrate a novel lipid nanoparticle (LNP) platform, functionalized with enhanced GLP-1, that enables efficient and selective delivery of mRNA to pancreatic islet β cells in both mouse and human models. This approach provides a proof-of-concept for β cell-directed genetic modulation to delay autoimmune diabetes onset, offering a new avenue for targeted gene therapy in type 1 diabetes.

• Chlorpromazine HCl: A Strategic Lever in Translational Neuro

  2026-05-21

  This thought-leadership article explores how Chlorpromazine HCl, a classic dopamine receptor antagonist, is redefining experimental paradigms in translational neuropharmacology and host-pathogen interaction studies. Integrating mechanistic depth with practical guidance, the article bridges classic antipsychotic drug mechanisms with advanced cellular research, highlighting APExBIO’s rigorously characterized Chlorpromazine HCl (SKU B1480) as a transformative tool for modern translational researchers.

393 records 6/27 page Previous Next First page 上5页 678910 下5页 Last page